Cryo-Cell International (CCEL) Chairman and Co-CEO David Portnoy recently invested $189,986 to acquire 42,900 shares at $4.43 each, marking his fourth purchase in the past year. Concurrently, Arrow Financial (AROW) CFO Penko Krassimir Ivanov bought 5,000 shares for $145,499 at $29.10 apiece, his third such transaction in twelve months. These significant insider buys, totaling over $335,000 across both firms, signal executive conviction despite CCEL trading down 3.5% and AROW down 0.5% on Friday.
Significant insider buying activity has been reported at Cryo-Cell International (CCEL) and Arrow Financial (AROW), signaling strong executive conviction. At CCEL, Chairman and Co-CEO David Portnoy executed his fourth purchase in the last year, acquiring 42,900 shares for $189,986 at an average cost of $4.43 per share. This brings his total investment over the period to $285,581 at a consistent average of $4.44 per share. While this latest purchase is already showing a 6.1% unrealized gain based on the day's high, the stock itself closed down 3.5%. Similarly, at AROW, CFO Penko Krassimir Ivanov purchased 5,000 shares for $145,499, marking his third buy in twelve months and increasing his total investment to $391,248 at an average price of $29.14 per share, even as the stock traded down 0.5%. The recurring nature and substantial capital committed by C-suite executives in both firms, at very consistent price levels, suggest a belief that their respective stocks are fundamentally undervalued by the market, notwithstanding the minor daily price weakness.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment
